Megna Michael R

CIK 00014645832 companiesROCKLAND, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001464583

Recent Transactions

50 trades

Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-10-20−12,787→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$10.76/sh+12,787→ 77,536 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$11.97/sh+9,831→ 64,749 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$38.72/sh−37,255→ 40,281 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$11.10/sh+9,831→ 54,918 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-10-20−791→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-10-20−9,831→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$39.31/sh−13,235→ 27,046 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$15.50/sh+791→ 38,892 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-20$12.97/sh+6,195→ 45,087 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-10-20−9,831→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-10-20−6,195→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-10-04−175→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-04+175→ 38,186 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-10-04$38.49/sh−85→ 38,101 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-03$34.84/sh−11,000→ 38,011 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-09-03−11,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-03$17.92/sh+11,000→ 49,011 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-02+774→ 38,386 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-09-02−774→ 0 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-02$34.28/sh−375→ 38,011 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-09-01−2,363→ 7,087 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-09-01−2,557→ 5,115 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-09-01+21,150→ 21,150 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-01$33.49/sh−4,282→ 37,612 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-01+3,933→ 41,894 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-01+2,363→ 35,404 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-09-01+10,575→ 10,575 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-09-01−3,933→ 3,932 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-09-01+2,557→ 37,961 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-04−17,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-08-04$15.52/sh+17,000→ 50,041 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-08-04$32.35/sh−17,000→ 33,041 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-07-15$15.63/sh+495→ 33,041 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03−15,211→ 791 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-03$15.50/sh+15,211→ 47,757 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-03$28.75/sh−15,211→ 32,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-05-07$11.97/sh+14,420→ 50,193 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-05-07$15.50/sh+2,998→ 35,773 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-05-07−2,998→ 16,002 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-05-07$26.69/sh−17,647→ 32,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-05-07−229→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-05-07−14,420→ 17,040 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-05-07$8.83/sh+229→ 32,775 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Performance Share Option
2025-05-01+5,285→ 5,285 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Performance Share Option
2025-05-01+5,456→ 5,456 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Performance Share Unit
2025-05-01+3,433→ 3,433 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Performance Share Unit
2025-05-01+3,270→ 3,270 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-04-07$20.28/sh−1,666→ 32,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2025-04-07−3,933→ 3,932 total

Companies

Recent Filings

Address

C/O BIOSPHERE MEDICAL 1050 HINGHAM STREET

ROCKLAND, MA, 02370

View on SEC.gov